Defining and modeling known adverse outcome pathways: Domoic acid and neuronal signaling as a case study.
An adverse outcome pathway (AOP) is a sequence of key events from a molecular-level initiating event and an ensuing cascade of steps to an adverse outcome with population-level significance. To implement a predictive strategy for ecotoxicology, the multiscale nature of an AOP requires computational models to link salient processes (e.g., in chemical uptake, toxicokinetics, toxicodynamics, and population dynamics). A case study with domoic acid was used to demonstrate strategies and enable generic recommendations for developing computational models in an effort to move toward a toxicity testing paradigm focused on toxicity pathway perturbations applicable to ecological risk assessment. Domoic acid, an algal toxin with adverse effects on both wildlife and humans, is a potent agonist for kainate receptors (ionotropic glutamate receptors whose activation leads to the influx of Na(+) and Ca²(+)). Increased Ca²(+) concentrations result in neuronal excitotoxicity and cell death, primarily in the hippocampus, which produces seizures, impairs learning and memory, and alters behavior in some species. Altered neuronal Ca²(+) is a key process in domoic acid toxicity, which can be evaluated in vitro. Furthermore, results of these assays would be amenable to mechanistic modeling for identifying domoic acid concentrations and Ca²(+) perturbations that are normal, adaptive, or clearly toxic. In vitro assays with outputs amenable to measurement in exposed populations can link in vitro to in vivo conditions, and toxicokinetic information will aid in linking in vitro results to the individual organism. Development of an AOP required an iterative process with three important outcomes: a critically reviewed, stressor-specific AOP; identification of key processes suitable for evaluation with in vitro assays; and strategies for model development.
Watanabe
Karen H
KH
Oregon Health & Science University, Beaverton, USA.
Andersen
Melvin E
ME
Basu
Niladri
N
Carvan
Michael J
MJ
Crofton
Kevin M
KM
King
Kerensa A
KA
Suñol
Cristina
C
Tiffany-Castiglioni
Evelyn
E
Schultz
Irvin R
IR
D004305:Dose-Response Relationship, Drug; D004784:Environmental Monitoring / Q000379:methods*; D004785:Environmental Pollutants / Q000737:chemistry / Q000633:toxicity*; D007608:Kainic Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000633:toxicity; D007700:Kinetics; D008962:Models, Theoretical; D009474:Neurons / Q000187:drug effects*; D018570:Risk Assessment; D015398:Signal Transduction / Q000187:drug effects*; D018675:Toxicity Tests
D004785:Environmental Pollutants; C012301:domoic acid; D007608:Kainic Acid